Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SKYESkye Bioscience, Inc.

Nasdaq · CIK 0001516551
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts439

Identity from submissions API

NameSkye Bioscience, Inc.
CIK0001516551
TickersSKYE
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN450692882
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone(858) 410-0266
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Emerald Bioscience, Inc. (2019-03-25T04:00:00.000Z → 2021-01-07T05:00:00.000Z)
  • Nemus Bioscience, Inc. (2014-11-03T05:00:00.000Z → 2019-03-14T04:00:00.000Z)
  • LOAD GUARD LOGISTICS, INC. (2012-11-08T05:00:00.000Z → 2014-10-30T04:00:00.000Z)
  • LOAD GUARD TRANSPORTATION, INC. (2011-03-25T04:00:00.000Z → 2012-11-07T05:00:00.000Z)
Business address
11250 EL CAMINO REAL, SUITE 100
SAN DIEGO
CA
92130
CA
Mailing address
11250 EL CAMINO REAL, SUITE 100
SAN DIEGO
CA
92130
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

634 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 10-Q 10-Q 0001628280-26-073810 001-42009 261552281 34 5704852 1 1
2026-11-12 DEFA14A DEFA14A 0001628280-26-073123 001-42009 261543413 34 34314
2026-11-12 8-K 8-K 8.01 0001628280-26-073120 001-42009 261543380 34 148328 1 1
2026-10-28 PRER14A PRER14A 0001628280-26-067744 001-42009 261492578 34 10431996
2026-10-26 PREM14A PREM14A 0001628280-26-067322 001-42009 261486765 34 10659798 1 1
2026-10-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001214659-26-012924 005-87830 261460729 34 27144
2026-09-24 4 xslF345X06/form4-09242026_080953.xml 0001598549-26-000015 12537
2026-09-24 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001873545-26-000009 005-87830 261405117 34 22682
2026-09-24 4 xslF345X06/form4-09242026_080923.xml 0001231919-26-001224 25174
2026-09-18 4 xslF345X06/form4-09182026_100915.xml 0001598549-26-000013 9682
2026-09-18 4 xslF345X06/form4-09182026_100949.xml 0001231919-26-001197 22319
2026-09-11 DEFA14A DEFA14A 0001628280-26-061564 001-42009 261374575 34 39264
2026-09-11 8-K 8-K 1.02,5.02,8.01 0001628280-26-061558 001-42009 261374516 34 154312 1 1
2026-08-24 DEFA14A DEFA14A 0001628280-26-058615 001-42009 261310516 34 577569
2026-08-24 8-K 8-K 1.01,3.02,9.01 0001628280-26-058605 001-42009 261310474 34 801849 1 1
2026-08-20 4 xslF345X06/form4-08202026_090822.xml 0001598549-26-000005 20141
2026-08-20 4 xslF345X06/form4-08202026_090856.xml 0001231919-26-000959 32778
2026-08-20 DEFA14A DEFA14A 0001628280-26-058121 001-42009 261297074 34 35810
2026-08-20 8-K/A 8-K/A 3.03 0001628280-26-058120 001-42009 261297072 34 147980 1 1
2026-08-19 DEFA14A DEFA14A 0001628280-26-057806 001-42009 261292595 34 37694
2026-08-19 8-K 8-K 3.01 0001628280-26-057804 001-42009 261292593 34 150477 1 1
2026-08-18 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001873545-26-000007 005-87830 261292596 34 32490
2026-08-14 DEFA14A DEFA14A 0001628280-26-056979 001-42009 261277205 34 6432780
2026-08-14 10-Q 10-Q 0001628280-26-056968 001-42009 261276870 34 5200524 1 1
2026-08-14 8-K 8-K 1.01,3.02,3.03,5.01,5.02,5.03,7.01,9.01 0001628280-26-056966 001-42009 261276857 34 7013012 1 1
2026-08-07 4 FORM 4 0001628280-26-054941 6369
2026-06-23 8-K 8-K 8.01 0001628280-26-044747 001-42009 261108262 34 136787 1 1
2026-05-29 8-K 8-K 5.03,5.07,9.01 0001628280-26-039233 001-42009 261045630 34 186226 1 1
2026-05-15 8-K 8-K 3.01 0001628280-26-035535 001-42009 26986568 34 135851 1 1
2026-05-11 10-Q 10-Q 0001628280-26-033417 001-42009 26962969 34 4171766 1 1
2026-04-28 3 FORM 3 0001628280-26-028062 323410
2026-04-16 ARS ARS 0001628280-26-025370 001-42009 26865724 34 26585064
2026-04-16 DEFA14A DEFA14A 0001628280-26-025369 001-42009 26865723 34 415987
2026-04-16 DEF 14A DEF 14A 0001628280-26-025368 001-42009 26865722 34 4960725 1 1
2026-04-06 PRE 14A PRE 14A 0001628280-26-023937 001-42009 26842145 34 1915808
2026-04-06 PREM14A DEF 14A 0001628280-26-023908 001-42009 26841391 34 1918368
2026-04-06 8-K/A 8-K/A 5.02 0001628280-26-023903 001-42009 26841295 34 134749 1 1
2026-04-03 8-K 8-K 5.02,9.01 0001628280-26-023699 001-42009 26838706 34 266918 1 1
2026-04-02 4 FORM 4 0001628280-26-023358 5686
2026-04-02 4 FORM 4 0001628280-26-023356 30267
2026-04-02 4 FORM 4 0001628280-26-023354 5672
2026-04-02 3/A FORM 3/A 0001628280-26-023351 11530
2026-04-02 4 FORM 4 0001628280-26-023349 5632
2026-04-02 4 FORM 4 0001628280-26-023346 5674
2026-04-02 4 FORM 4 0001628280-26-023343 5731
2026-04-02 4 FORM 4 0001628280-26-023340 34045
2026-04-02 4 FORM 4 0001628280-26-023337 33677
2026-03-19 8-K 8-K 3.01 0001628280-26-019878 001-42009 26775239 34 136747 1 1
2026-03-11 S-8 S-8 0001628280-26-016585 333-294195 26740724 33 313518 1 1
2026-03-10 8-K 8-K 2.02 0001628280-26-016400 001-42009 26739186 34 352733 1 1
2026-03-10 10-K 10-K 0001628280-26-016394 001-42009 26739130 34 10448992 1 1
2026-02-20 8-K 8-K 5.02 0001628280-26-010186 001-42009 26659790 34 30447
2026-02-09 4 FORM 4 0001628280-26-006631 5596
2026-02-09 4 FORM 4 0001628280-26-006626 5539
2026-02-09 4 FORM 4 0001628280-26-006625 5551
2026-02-09 4 FORM 4 0001628280-26-006624 5723
2026-02-09 4 FORM 4 0001628280-26-006623 5594
2026-02-09 4 FORM 4 0001628280-26-006622 5497
2026-02-09 4 FORM 4 0001628280-26-006621 5537
2026-02-09 4 FORM 4 0001628280-26-006620 5583
2026-02-09 4 FORM 4 0001628280-26-006619 5618
2026-02-09 4 FORM 4 0001628280-26-006618 5589
2026-02-02 8-K 8-K 7.01,8.01,9.01 0001628280-26-004451 001-42009 26585667 34 8066266 1 1
2025-12-23 8-K 8-K 1.01 0001628280-25-058729 001-42009 251600461 34 142703 1 1
2025-12-16 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001873545-25-000004 005-87830 251575745 34 47925
2025-11-10 8-K 8-K 2.02,9.01 0001628280-25-051035 001-42009 251466266 34 333036 1 1
2025-11-10 10-Q 10-Q 0001628280-25-051031 001-42009 251466247 34 4548849 1 1
2025-10-06 8-K 8-K 7.01,9.01 0001628280-25-044223 001-42009 251375686 34 234253 1 1
2025-08-22 4 xslF345X05/form4-08222025_110825.xml 0001415889-25-022808 12967
2025-08-22 4 xslF345X05/form4-08222025_110831.xml 0001415889-25-022806 25107
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193805-25-001194 005-87830 251219945 34 8608
2025-08-07 8-K 8-K 2.02,9.01 0001516551-25-000050 001-42009 251193950 34 347179 1 1
2025-08-07 10-Q 10-Q 0001516551-25-000049 001-42009 251193826 34 4376483 1 1
2025-06-11 8-K 8-K 4.01,5.07,9.01 0001516551-25-000046 001-42009 251040843 34 177772 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193805-25-000668 005-87830 25954158 34 8485
2025-05-08 8-K 8-K 2.02,9.01 0001516551-25-000043 001-42009 25925918 34 322786 1 1
2025-05-08 10-Q 10-Q 0001516551-25-000042 001-42009 25925872 34 4049463 1 1
2025-04-25 3 FORM 3 0001516551-25-000038 17583
2025-04-25 ARS ARS 0001516551-25-000037 001-42009 25873670 34 20625789
2025-04-25 DEFA14A DEFA14A 0001516551-25-000036 001-42009 25873641 34 410902
2025-04-25 DEF 14A DEF 14A 0001516551-25-000035 001-42009 25873622 34 4145085
2025-04-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001178913-25-001277 005-87830 25829325 34 12143
2025-03-20 S-8 S-8 0001516551-25-000030 333-285957 25756561 33 196806
2025-03-20 8-K 8-K 2.02,9.01 0001516551-25-000028 001-42009 25756417 34 371160 1 1
2025-03-20 10-K 10-K 0001516551-25-000027 001-42009 25756399 34 13977730 1 1
2025-02-28 4/A FORM 4/A 0001516551-25-000022 7624
2025-02-26 4 FORM 4 0001516551-25-000020 5604
2025-02-26 4 FORM 4 0001516551-25-000018 5731
2025-02-26 4 FORM 4 0001516551-25-000016 5545
2025-02-26 4 FORM 4 0001516551-25-000014 5548
2025-02-26 4 FORM 4 0001516551-25-000012 5559
2025-02-26 4 FORM 4 0001516551-25-000010 5596
2025-02-26 4 FORM 4 0001516551-25-000008 5505
2025-02-26 4 FORM 4 0001516551-25-000006 5591
2025-02-26 4 FORM 4 0001516551-25-000004 5622
2025-02-26 8-K 8-K 5.02,9.01 0001516551-25-000002 001-42009 25671553 34 350696 1 1
2025-02-05 UPLOAD filename1.pdf 0000000000-25-001232 000-55136 39990
2024-12-23 CORRESP filename1.htm 0001516551-24-000122 35110
2024-12-19 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-24-029910 005-87830 241564591 34 55696
2024-12-16 UPLOAD filename1.pdf 0000000000-24-013796 000-55136 43132
2024-11-20 4 FORM 4 0001516551-24-000119 7176
2024-11-19 4 FORM 4 0001516551-24-000117 7318
2024-11-19 4 FORM 4 0001516551-24-000116 8020
2024-11-19 4 FORM 4 0001516551-24-000114 6941
2024-11-15 144 xsl144X01/primary_doc.xml 0001967940-24-000093 001-42009 241469231 33 4721
2024-11-15 144 xsl144X01/primary_doc.xml 0001967940-24-000092 001-42009 241469217 33 4623
2024-11-15 144 xsl144X01/primary_doc.xml 0001967940-24-000091 001-42009 241469014 33 4577
2024-11-15 144 xsl144X01/primary_doc.xml 0001967940-24-000090 001-42009 241468962 33 4578
2024-11-14 SC 13G/A JANUS CLOSEOUT 0001274173-24-000092 005-87830 241458063 34 12742
2024-11-14 SC 13G/A AMENDMENT TO FORM SC 13G 0001839882-24-039025 005-87830 241457726 34 74163
2024-11-07 S-8 S-8 0001516551-24-000112 333-283068 241436101 33 91655
2024-11-07 10-Q 10-Q 0001516551-24-000110 001-42009 241435725 34 5741003 1 1
2024-11-07 8-K 8-K 2.02,9.01 0001516551-24-000108 001-42009 241435455 34 345763 1 1
2024-10-30 4 FORM 4 0001516551-24-000103 5591
2024-10-30 4 FORM 4 0001516551-24-000102 5731
2024-10-30 4 FORM 4 0001516551-24-000101 5597
2024-10-30 4 FORM 4 0001516551-24-000100 5604
2024-10-30 4 FORM 4 0001516551-24-000099 5545
2024-10-30 4 FORM 4 0001516551-24-000098 5559
2024-10-30 4 FORM 4 0001516551-24-000097 5505
2024-10-30 4 FORM 4 0001516551-24-000096 5545
2024-10-29 8-K 8-K 5.02,8.01,9.01 0001516551-24-000093 001-42009 241406790 34 172642 1 1
2024-10-24 8-K 8-K 5.02,5.07,9.01 0001516551-24-000091 001-42009 241393334 34 161619 1 1
2024-09-23 DEF 14A DEF 14A 0001516551-24-000089 001-42009 241317091 34 1318317
2024-09-13 4 xslF345X05/form4-09132024_100908.xml 0001415889-24-023401 14787
2024-09-13 4 xslF345X05/form4-09132024_100903.xml 0001415889-24-023399 26927
2024-09-13 PRE 14A PRE 14A 0001516551-24-000087 001-42009 241298662 34 1308757
2024-09-04 4 FORM 4 0001516551-24-000084 5623
2024-09-04 8-K 8-K 5.02,7.01,9.01 0001516551-24-000085 001-42009 241278573 34 270121 1 1
2024-09-04 3 FORM 3 0001516551-24-000083 9285
2024-08-27 4 FORM 4 0001516551-24-000078 5872
2024-08-14 SC 13G JHG PLC OWNS >5% 0001274173-24-000079 005-87830 241209236 34 13212
2024-08-12 S-8 S-8 0001516551-24-000074 333-281461 241194166 33 115360
2024-08-09 S-8 S-8 0001516551-24-000073 333-281460 241194155 33 97552
2024-08-09 10-Q 10-Q 0001516551-24-000070 001-42009 241194020 34 5243336 1 1
2024-07-05 4 FORM 4 0001516551-24-000068 5568
2024-07-05 3 FORM 3 0001516551-24-000067 318369
2024-07-03 8-K 8-K 5.02,7.01,9.01 0001516551-24-000064 001-42009 241098238 34 180575 1 1
2024-06-10 8-K 8-K 8.01,9.01 0001516551-24-000059 001-42009 241031612 34 178394 1 1
2024-05-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-17 16:15:00 9999999995-24-001575 333-279330 24962231 33 2041
2024-05-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-05-17 16:15:00 9999999995-24-001576 333-279331 24962229 33 2041
2024-05-17 424B3 424B3 0001628280-24-024078 333-279330 24960202 33 201201
2024-05-15 CORRESP filename1.htm 0001628280-24-023490 8196
2024-05-15 CORRESP filename1.htm 0001628280-24-023489 8196
2024-05-15 CORRESP filename1.htm 0001628280-24-023402 7956
2024-05-15 CORRESP filename1.htm 0001628280-24-023400 7956
2024-05-14 UPLOAD filename1.pdf 0000000000-24-005531 333-279331 40578
2024-05-14 UPLOAD filename1.pdf 0000000000-24-005527 333-279330 40571
2024-05-10 S-3 S-3 0001628280-24-022632 333-279331 24935194 33 1384175
2024-05-10 S-3 S-3 0001628280-24-022629 333-279330 24935144 33 340406
2024-05-10 10-Q 10-Q 0001516551-24-000055 001-42009 24934660 34 4481878 1 1
2024-04-26 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001628280-24-017677,2024-04-26 9999999995-24-001154 333-278286 24886336 33 2054
2024-04-24 POS AM POS AM 0001628280-24-017677 333-278286 24871167 33 413577
2024-04-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-10 16:15:00 9999999995-24-000923 333-278286 24837021 33 2041
2024-04-10 424B3 424B3 0001628280-24-015630 333-278286 24836304 33 2540313
2024-04-10 CERT SKYE_8-ACert.pdf 0001354457-24-000263 001-42009 24834441 34 218959
2024-04-10 8-A12B 8-A12B 0001628280-24-015551 001-42009 24834216 34 33530
2024-04-09 CORRESP filename1.htm 0001628280-24-015500 8647
2024-04-09 CORRESP filename1.htm 0001628280-24-015480 8739
2024-04-09 CORRESP filename1.htm 0001628280-24-015401 8645
2024-04-04 S-1/A S-1/A 0001628280-24-014904 333-278286 24824136 33 9604129 1 1
2024-04-03 8-K 8-K 7.01,9.01 0001516551-24-000052 000-55136 24819896 34 203470 1 1
2024-04-02 UPLOAD filename1.pdf 0000000000-24-003511 333-278286 40563
2024-03-27 S-1 S-1 0001628280-24-013372 333-278286 24792146 33 12515239 1 1
2024-03-27 D xslFormDX01/primary_doc.xml 06b 0000925421-24-000004 021-508708 24785130 33 14822
2024-03-22 10-K FORM 10-K 0001516551-24-000048 000-55136 24772855 34 13320145 1 1
2024-03-15 4 xslF345X05/form4-03152024_040305.xml 0001415889-24-008107 19913
2024-03-15 4 xslF345X05/form4-03152024_040302.xml 0001415889-24-008106 7943
2024-03-13 SC 13D/A SC 13D/A 0001104659-24-034066 005-87830 24747492 34 175457
2024-03-13 8-K 8-K 1.01,3.02,9.01 0001516551-24-000045 000-55136 24746049 34 602035 1 1
2024-03-04 4 FORM 4 0001516551-24-000043 8074
2024-03-04 4 FORM 4 0001516551-24-000039 5623
2024-03-04 4 FORM 4 0001516551-24-000038 5663
2024-03-04 8-K 8-K 5.02,8.01,9.01 0001516551-24-000034 000-55136 24715247 34 167186 1 1
2024-03-04 3 FORM 3 0001516551-24-000032 9303
2024-03-04 4 FORM 4 0001516551-24-000030 5696
2024-03-04 4 FORM 4 0001516551-24-000027 5699
2024-03-04 4 FORM 4 0001516551-24-000025 5623
2024-03-04 4 FORM 4 0001516551-24-000022 5645
2024-03-04 4 FORM 4 0001516551-24-000020 8202
2024-03-04 3 FORM 3 0001516551-24-000018 9341
2024-03-04 4/A FORM 4/A 0001516551-24-000016 8423
2024-03-04 4/A FORM 4/A 0001516551-24-000014 8293
2024-03-01 4 FORM 4 0001516551-24-000012 8384
2024-03-01 4 FORM 4 0001516551-24-000010 8255
2024-02-12 8-K 8-K 8.01,9.01 0001516551-24-000008 000-55136 24620188 34 206656 1 1
2024-02-12 D xslFormDX01/primary_doc.xml 06b 0001516551-24-000003 021-504974 24618459 33 14074
2024-02-08 SC 13G SC 13G 0001178913-24-000414 005-87830 24607168 34 96357
2024-02-05 SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP 0001999371-24-001474 005-87830 24593201 34 85016
2024-02-02 4 FORM 4 SUBMISSION 0001209191-24-002649 8067
2024-02-02 4 FORM 4 SUBMISSION 0001209191-24-002643 19583
2024-01-31 SC 13D/A SC 13D/A 0001104659-24-008803 005-87830 24583086 34 174174
2024-01-29 8-K 8-K 1.01,3.02,7.01,8.01,9.01 0001516551-24-000002 000-55136 24570144 34 12236233 1 1
2023-12-22 S-8 S-8 0001516551-23-000107 333-276211 231506813 33 129403
2023-12-05 8-K 8-K 1.01,1.02,9.01 0001516551-23-000103 000-55136 231467466 34 764165 1 1
2023-11-14 10-Q 10-Q 0001516551-23-000100 000-55136 231400376 34 7034768 1 1
2023-11-07 8-K 8-K 5.03,9.01 0001516551-23-000083 000-55136 231381257 34 873000 1 1
2023-11-06 4 FORM 4 0001516551-23-000098 5536
2023-11-06 4 FORM 4 0001516551-23-000097 5536
2023-11-06 4 FORM 4 0001516551-23-000096 8150
2023-11-06 4 FORM 4 0001516551-23-000095 8016
2023-11-06 4 FORM 4 0001516551-23-000094 5612
2023-11-06 4 FORM 4 0001516551-23-000093 5612
2023-11-06 4 FORM 4 0001516551-23-000092 5558
2023-11-06 4 FORM 4 0001516551-23-000091 5609
2023-10-17 DEF 14C DEF 14C 0001516551-23-000081 000-55136 231328179 34 581618
2023-10-03 8-K 8-K 5.02,8.01,9.01 0001516551-23-000079 000-55136 231304378 34 168122 1 1
2023-10-03 PRE 14C PRE 14C 0001516551-23-000076 000-55136 231303726 34 586845
2023-09-07 8-K 8-K 3.03,5.03,7.01,9.01 0001516551-23-000073 000-55136 231241728 34 716865 1 1
2023-09-01 8-K/A 8-K/A 5.02 0001516551-23-000071 000-55136 231229890 34 156744 1 1
2023-08-31 4/A FORM 4/A 0001516551-23-000069 13069
2023-08-29 4 FORM 4 0001516551-23-000068 5617
2023-08-29 4 FORM 4 0001516551-23-000066 5580
2023-08-29 4 FORM 4 0001516551-23-000064 8163
2023-08-29 4 FORM 4 0001516551-23-000062 12076
2023-08-29 4 FORM 4 0001516551-23-000060 5545
2023-08-29 4 FORM 4 0001516551-23-000058 5599
2023-08-29 4 FORM 4 0001516551-23-000056 5523
2023-08-29 4 FORM 4 0001516551-23-000054 5523
2023-08-29 D xslFormDX01/primary_doc.xml 06b 0000925421-23-000018 021-490948 231222716 33 12673
2023-08-28 3 FORM 3 SUBMISSION 0001209191-23-047511 19517
2023-08-28 SC 13G SC 13G 0001104659-23-096005 005-87830 231215770 34 73126
2023-08-28 3 FORM 3 SUBMISSION 0001209191-23-047509 11716
2023-08-28 SC 13D SC 13D 0001104659-23-096002 005-87830 231215719 34 207357
2023-08-22 4 FORM 4 0001516551-23-000052 377202
2023-08-22 3 FORM 3 0001516551-23-000051 363996
2023-08-22 3 FORM 3 0001516551-23-000050 319248
2023-08-21 8-K 8-K 1.01,2.01,2.03,3.02,5.02,7.01,9.01 0001516551-23-000046 000-55136 231187411 34 35183889 1 1
2023-08-07 10-Q 10-Q 0001516551-23-000044 000-55136 231148106 34 6649133 1 1
2023-05-12 10-Q 10-Q 0001516551-23-000041 000-55136 23912761 34 5981219 1 1
2023-03-31 10-K 10-K 0001516551-23-000038 000-55136 23787802 34 10621807 1 1
2023-03-27 8-K/A 8-K/A 5.02,9.01 0001516551-23-000034 000-55136 23764633 34 148510 1 1
2023-03-20 SC 13D/A SC 13D/A 0001140361-23-012381 005-87830 23744125 34 64875
2023-03-17 4 FORM 4 0001567619-23-005234 17457
2023-03-03 3/A FORM 3/A 0001516551-23-000030 3747
2023-02-23 8-K 8-K 1.01,1.02,3.02,9.01 0001516551-23-000027 000-55136 23661029 34 274911 1 1
2023-02-16 3 FORM 3 0001516551-23-000024 342459
2023-02-16 4 FORM 4 0001516551-23-000022 5600
2023-02-16 8-K 8-K 5.02,8.01,9.01 0001516551-23-000020 000-55136 23639375 34 180267 1 1
2023-02-15 8-K 8-K 1.01,2.01,8.01,9.01 0001516551-23-000018 000-55136 23635716 34 232742 1 1
2023-01-27 8-K 8-K 1.01,7.01,9.01 0001516551-23-000016 000-55136 23559479 34 249098 1 1
2023-01-09 4/A FORM 4/A 0001516551-23-000014 5700
2023-01-09 4 FORM 4 0001516551-23-000012 5651
2023-01-09 4 FORM 4 0001516551-23-000010 5594
2023-01-09 4 FORM 4 0001516551-23-000008 5615
2023-01-06 4 FORM 4 0001516551-23-000006 5618
2023-01-06 8-K 8-K 1.01,5.02,9.01 0001516551-23-000004 000-55136 23515711 34 180160 1 1
2022-12-19 8-K 8-K 1.01,9.01 0001516551-22-000054 000-55136 221469272 34 266056 1 1
2022-11-23 8-K 8-K 1.01,3.03,9.01 0001516551-22-000052 000-55136 221417161 34 207286 1 1
2022-11-15 3/A FORM 3/A 0001516551-22-000050 341543
2022-11-15 4 FORM 4 0001516551-22-000047 16296
2022-11-15 4 FORM 4 0001516551-22-000045 16558
2022-11-15 3 FORM 3 0001516551-22-000042 3351
2022-11-14 10-Q 10-Q 0001516551-22-000040 000-55136 221384298 34 10239289 1 1
2022-10-19 8-K 8-K 1.01,2.03,9.01 0001516551-22-000037 000-55136 221316789 34 303477 1 1
2022-10-03 8-K 8-K 4.01,5.07,7.01,9.01 0001516551-22-000033 000-55136 221288486 34 214386 1 1
2022-09-01 DEFA14A DEFA14A 0001516551-22-000030 000-55136 221220945 34 309201
2022-08-31 DEFM14A DEFM14A 0001516551-22-000028 000-55136 221218810 34 5525337
2022-08-15 10-Q 10-Q 0001516551-22-000022 000-55136 221166783 34 6499783 1 1
2022-08-15 PREM14A skyebioscienceincproxy.htm 0001640334-22-001763 000-55136 221162025 34 5770298
2022-07-21 8-K 8-K 1.01,9.01 0001516551-22-000018 000-55136 221095340 34 209080 1 1
2022-06-17 8-K 8-K 1.01,4.01,5.02,9.01 0001516551-22-000016 000-55136 221025128 34 226232 1 1
2022-05-23 8-K 8-K 1.01,5.02,9.01 0001516551-22-000013 000-55136 22952675 34 365656 1 1
2022-05-12 8-K 8-K 1.01,3.02,5.02,8.01,9.01 0001516551-22-000010 000-55136 22915970 34 1650591 1 1
2022-05-06 10-Q 10-Q 0001516551-22-000006 000-55136 22902268 34 5259177 1 1
2022-03-28 10-K 10-K 0001516551-22-000004 000-55136 22772917 34 10911935 1 1
2022-01-31 5 FORM 5 0001640334-22-000206 16177
2022-01-31 SC 13D/A SC 13D/A 0001640334-22-000205 005-87830 22572604 34 44763
2022-01-05 SC 13G/A SABBY 13G-A SKYE 1.05.22 0001535610-22-000045 005-87830 22510318 34 13595
2021-12-20 8-K 8-K 5.02,8.01,9.01 0001516551-21-000031 000-55136 211506172 34 186560 1 1
2021-12-16 4 FORM 4 0001516551-21-000029 351349
2021-12-16 4 FORM 4 0001516551-21-000027 7477
2021-12-16 4 FORM 4 0001516551-21-000025 348555
2021-12-16 3 FORM 3 0001516551-21-000023 346301
2021-11-10 424B3 424B3 0001516551-21-000021 333-223895 211394638 33 795866
2021-11-10 10-Q 10-Q 0001516551-21-000020 000-55136 211394637 34 6787437 1 1
2021-10-15 8-K 8-K 1.01,8.01,9.01 0001516551-21-000017 000-55136 211326607 34 331307 1 1
2021-10-06 8-K 8-K 5.02,8.01,9.01 0001516551-21-000015 000-55136 211308523 34 285968 1 1
2021-10-05 4 FORM 4 0001516551-21-000014 5675
2021-10-05 3 FORM 3 0001516551-21-000012 4672
2021-09-30 8-K 8-K 7.01,9.01 0001516551-21-000009 000-55136 211293080 34 177164 1 1
2021-09-28 8-K FORM 8-K 1.01,8.01,9.01 0001640334-21-002419 000-55136 211283726 34 784629 1 1
2021-09-28 424B5 424(B)(5) 0001640334-21-002413 333-258243 211283687 33 372151
2021-09-16 4 FORM 4 0001628280-21-018756 5615
2021-09-16 4 FORM 4 0001628280-21-018755 5462
2021-09-16 4 FORM 4 0001628280-21-018754 5558
2021-09-15 8-K 8-K 5.02,8.01,9.01 0001628280-21-018623 000-55136 211253855 34 24394796 1 1
2021-08-09 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-08-09 16:00:00 9999999995-21-003111 333-258243 211158263 33 2001
2021-08-06 424B3 424B3 0001628280-21-015973 333-223895 211150377 33 686656
2021-08-06 10-Q 10-Q 0001628280-21-015972 000-55136 211150375 34 8232344 1 1
2021-08-05 CORRESP filename1.htm 0001640334-21-001775 7336
2021-08-04 UPLOAD filename1.pdf 0000000000-21-009575 40473
2021-07-29 S-3 FORM S-3 0001640334-21-001707 333-258243 211124345 33 276005
2021-07-26 4 FORM 4 0001140361-21-025590 5273
2021-07-26 3 FORM 3 0001140361-21-025587 2936
2021-07-26 8-K FORM 8-K 5.02,8.01,9.01 0001640334-21-001671 000-55136 211113415 34 28739
2021-07-22 8-K FORM 8-K 1.01,3.02,9.01 0001640334-21-001618 000-55136 211106049 34 153829
2021-05-07 424B3 424B3 0001628280-21-009449 333-223895 21900336 33 562721
2021-05-07 10-Q 10-Q 0001628280-21-009446 000-55136 21900321 34 4953902 1 1
2021-03-02 424B3 424B3 0001640334-21-000487 333-223895 21700868 33 1167944
2021-03-02 10-K FORM 10-K 0001640334-21-000483 000-55136 21700776 34 11691862 1
2021-02-16 SC 13G/A d8805415_13g-a.htm 0000919574-21-001727 005-87830 21641160 34 113723
2021-02-05 SC 13G/A sc13ga110022skye_02052021.htm 0000921895-21-000235 005-87830 21596889 34 210645
2021-02-03 8-K FORM 8-K 5.07 0001640334-21-000270 000-55136 21587242 34 29503
2021-01-19 8-K FORM 8-K 5.03,8.01,9.01 0001640334-21-000128 000-55136 21534531 34 446850
2021-01-07 SC 13G/A SABBY 13G-A EMBI 1.07.21 0001535610-21-000048 005-87830 21513073 34 13600
2020-12-22 DEF 14A DEF 14A 0001640334-20-003129 000-55136 201408491 34 556281
2020-12-11 PRE 14A PRE 14A 0001640334-20-003053 000-55136 201384521 34 359409
2020-11-09 424B3 424B3 0001640334-20-002735 333-223895 201295498 33 592389
2020-11-06 10-Q FORM 10-Q 0001640334-20-002732 000-55136 201295100 34 5103864 1
2020-10-07 3 FORM 3 0001640334-20-002492 3296
2020-09-28 8-K FORM 8-K 5.02 0001640334-20-002408 000-55136 201201616 34 13448
2020-08-17 SC 13D/A SC 13D/A 0001640334-20-002157 005-87830 201107235 34 32142
2020-08-13 4/A FORM 4 A 0001640334-20-002100 5708
2020-08-13 424B3 424B3 0001640334-20-002097 333-223895 201100298 33 490952
2020-08-13 10-Q FORM 10-Q 0001640334-20-002095 000-55136 201100259 34 4268318 1
2020-08-13 S-8 FORM S-8 0001640334-20-002064 333-245177 201097002 33 51804
2020-08-12 8-K FORM 8-K 5.02,8.01,9.01 0001640334-20-002056 000-55136 201095938 34 146207
2020-08-12 4 PRIMARY DOCUMENT 0001640334-20-002044 5636
2020-08-12 3 PRIMARY DOCUMENT 0001640334-20-002043 3137
2020-08-11 4 FORM 4 0001640334-20-002029 5107
2020-08-11 4 FORM 4 0001640334-20-002027 7174
2020-08-11 4 FORM 4 0001640334-20-002026 7020
2020-08-11 4 FORM 4 0001640334-20-002025 5687
2020-08-11 4 FORM 4 0001640334-20-002024 5650
2020-08-10 SC 13G d8589525_13-g.htm 0000919574-20-004946 005-87830 201089959 34 104524
2020-08-07 SC 13G sc13g10022eme_08062020.htm 0000921895-20-002118 005-87830 201083008 34 232014
2020-08-05 8-K FORM 8-K 1.01,8.01,9.01 0001640334-20-001960 000-55136 201075165 34 386020
2020-08-03 424B4 424B4 0001640334-20-001952 333-239826 201069902 33 1672415
2020-07-31 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-07-31 09:00:00 9999999995-20-001992 333-239826 201067701 33 1990
2020-07-31 SC 13G SABBY 13G EMBI 7.31.20 0001535610-20-000109 005-87830 201064666 34 13561
2020-07-31 S-1MEF FORM S-1MEF 0001640334-20-001921 333-240226 201063924 33 55923
2020-07-29 CORRESP filename1.htm 0001640334-20-001887 10118
2020-07-28 S-1/A FORM S-1 AMENDMENT NO. 1 0001640334-20-001865 333-239826 201054294 33 9646368 1
2020-07-16 UPLOAD filename1.pdf 0000000000-20-006495 40510
2020-07-13 S-1 FORM S-1 0001640334-20-001743 333-239826 201024825 33 9107389 1
2020-06-22 8-K FORM 8-K 2.03 0001640334-20-001567 000-55136 20979699 34 13318
2020-05-15 3 FORM 3 0001640334-20-001229 3221
2020-05-08 424B3 424B3 0001640334-20-001120 333-223895 20860342 33 428721
2020-05-08 10-Q FORM 10-Q 0001640334-20-001119 000-55136 20860316 34 3916228 1
2020-04-29 8-K FORM 8-K 1.01,2.03,5.02,9.01 0001640334-20-000959 000-55136 20830935 34 218347
2020-03-23 424B3 424B3 0001640334-20-000583 333-223895 20733441 33 1330654
2020-03-23 10-K FORM 10-K 0001640334-20-000582 000-55136 20733427 34 7256834 1
2020-03-17 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001640334-20-000495,2020-03-17 9999999995-20-000578 333-234673 20723077 33 2002
2020-03-13 POS AM POS AM 0001640334-20-000495 333-234673 20711526 33 22666
2020-02-13 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001640334-20-000268,2020-02-13 9999999995-20-000343 333-231951 20613458 33 2002
2020-02-13 POS AM POS AM 0001640334-20-000268 333-231951 20608145 33 9847462 1
2020-02-11 POS AM POS AM 0001640334-20-000232 333-231951 20593322 33 9815664 1
2020-01-28 SC 13D/A SC 13D/A 0001640334-20-000164 005-87830 20554780 34 33057
2020-01-28 4 FORM 4 0001640334-20-000163 10274
2020-01-22 POS AM POS AM 0001640334-20-000136 333-231951 20539603 33 9725365 1
2019-12-31 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001640334-19-002671,2019-12-31 9999999995-20-000003 333-231951 20500007 33 2002
2019-12-24 POS AM POS AM 0001640334-19-002671 333-231951 191307906 33 9690057 1
2019-12-23 8-K FORM 8-K 1.01,1.02,5.02,8.01,9.01 0001640334-19-002653 000-55136 191303249 34 88788
2019-12-17 AW AW 0001640334-19-002599 333-231951 191288446 NE 5461
2019-12-09 POS AM POS AM 0001640334-19-002550 333-231951 191276063 33 22068
2019-11-21 8-K FORM 8-K 1.01,8.01,9.01 0001640334-19-002436 000-55136 191238104 34 276290
2019-11-20 8-K FORM 8-K 5.07 0001640334-19-002423 000-55136 191232968 34 14400
2019-11-14 424B3 424B3 0001640334-19-002297 333-231951 191215864 33 695178
2019-11-14 424B3 424B3 0001640334-19-002294 333-223895 191215820 33 698825
2019-11-14 10-Q FORM 10-Q 0001640334-19-002291 000-55136 191215805 34 5261012 1
2019-11-13 424B4 424B4 0001640334-19-002259 333-231951 191212934 33 1759969
2019-11-13 S-1MEF FORM S-1MEF 0001640334-19-002256 333-234673 191212928 33 62599
2019-10-30 DEF 14C DEF 14C 0001640334-19-002136 000-55136 191177103 34 138404
2019-10-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2019-10-28 16:30:00 9999999995-19-002407 333-231951 191174381 33 1990
2019-10-25 CORRESP filename1.htm 0001640334-19-002111 8401
2019-10-23 S-1/A FORM S-1 AMENDMENT NO. 1 0001640334-19-002094 333-231951 191162550 33 9660052 1
2019-08-27 8-K FORM 8-K 1.01,9.01 0001640334-19-001760 000-55136 191058207 34 49590
2019-08-23 SEC STAFF LETTER filename1.pdf 9999999997-19-006622 140123
2019-08-23 4 FORM 4 0001640334-19-001745 5540
2019-08-23 3 FORM 3 0001640334-19-001743 3231
2019-08-23 8-K FORM 8-K 8.01 0001640334-19-001741 000-55136 191047110 34 13283
2019-08-14 SEC STAFF LETTER filename1.pdf 9999999997-19-006482 147125
2019-08-09 424B3 424B3 0001640334-19-001575 333-223895 191013611 33 608386
2019-08-09 10-Q FORM 10-Q 0001640334-19-001572 000-55136 191013603 34 4365015 1
2019-08-08 8-K FORM 8-K 1.01,1.02,9.01 0001640334-19-001557 000-55136 191010713 34 34543
2019-06-11 UPLOAD filename1.pdf 0000000000-19-009726 46268
2019-06-04 S-1 FORM S-1 0001640334-19-001037 333-231951 19877131 33 8826528 1
2019-05-29 8-K FORM 8-K 1.01,7.01,9.01 0001640334-19-001000 000-55136 19862702 34 324584
2019-05-29 10-K/A FORM 10-K/A 0001640334-19-000998 000-55136 19862682 34 66281
2019-05-10 424B3 424B3 0001640334-19-000806 333-223895 19812424 33 504504
2019-05-10 10-Q FORM 10-Q 0001640334-19-000805 000-55136 19812414 34 12578885 1
2019-04-01 SC 13D/A SC 13D/A 0001640334-19-000475 005-87830 19718734 34 32104
2019-04-01 8-K FORM 8-K 2.03,3.02 0001640334-19-000473 000-55136 19718728 34 15883
2019-04-01 4 FORM 4 0001640334-19-000471 9446
2019-03-26 CT ORDER filename1.pdf 20190326,20190326 9999999997-19-001964 000-55136 19704852 34 92386
2019-03-25 8-K FORM 8-K 5.03,8.01,9.01 0001640334-19-000432 000-55136 19702839 34 969709
2019-03-14 424B3 424B3 0001640334-19-000381 333-223895 19681397 33 1288611
2019-03-14 10-K FORM 10-K 0001640334-19-000379 000-55136 19681330 34 7309909 1
2019-03-04 8-K FORM 8-K 1.01,7.01,9.01 0001640334-19-000347 000-55136 19654625 34 143845
2019-03-04 DEF 14C DEF 14C 0001640334-19-000344 000-55136 19654481 34 646590
2019-02-20 PRE 14C PRE 14C 0001640334-19-000294 000-55136 19616715 34 637258
2019-02-04 SC 13D/A SC 13D/A 0001640334-19-000147 005-87830 19561314 34 32214
2019-02-01 4 FORM 4 SUBMISSION 0001209191-19-006473 9253
2019-02-01 8-K FORM 8-K 2.03,3.02 0001640334-19-000140 000-55136 19560358 34 15473
2018-12-28 4 FORM 4 SUBMISSION 0001209191-18-064353 5191
2018-11-16 8-K FORM 8-K 5.03,9.01 0001640334-18-002213 000-55136 181188744 34 540253
2018-11-15 D xslFormDX01/primary_doc.xml 06b 0001738287-18-000002 021-325866 181185566 33 9872
2018-11-14 424B3 424B3 0001640334-18-002125 333-223895 181179466 33 435738
2018-11-14 10-Q FORM 10-Q 0001640334-18-002123 000-55136 181179442 34 7847681 1

Latest XBRL company facts

One latest value per concept from companyfacts (439 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 4.42M 2026-11-10 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
dei EntityPublicFloat Entity Public Float USD 129.53M 2025-06-30 2025 FY 10-K 2026-03-10 0001628280-26-016394
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 339,391 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025368
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 882,264 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025368
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD -148,284 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025368
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.36M 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025368
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 18.51 2025-01-01 2025-12-31 DEF 14A 2026-04-16 0001628280-26-025368
ffd NetFeeAmt NetFeeAmt USD 271.9 2026-10-26 PREM14A 2026-10-26 0001628280-26-067322
ffd TtlFeeAmt TtlFeeAmt USD 271.9 2026-10-26 PREM14A 2026-10-26 0001628280-26-067322
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-26 PREM14A 2026-10-26 0001628280-26-067322
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-26 PREM14A 2026-10-26 0001628280-26-067322
ffd TtlTxValtn TtlTxValtn USD 3.13M 2026-10-26 PREM14A 2026-10-26 0001628280-26-067322
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 6,048 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.45M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap AccountsPayableInterestBearingInterestRate Accounts Payable, Interest-bearing, Interest Rate pure 0.041 2026-02-01 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 11,300 2023-09-30 2023 Q3 10-Q 2023-11-14 0001516551-23-000100
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 800 2016-06-30 2016 Q2 10-Q 2016-08-12 0001640334-16-001531
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 5,455 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 20,057 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 61,547 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 84,954 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 59,753 2013-07-31 2013 Q3 10-Q 2013-09-16 0001557240-13-000264
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 211.46M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 30,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 925,550 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 175,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.20M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 4,180 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-27 0001557240-15-000195
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 925,550 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap AdvancesFairValueDisclosure Advances, Fair Value Disclosure USD 1.88M 2019-12-31 2020 Q3 10-Q 2020-11-06 0001640334-20-002732
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 4.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 582,550 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 16,456 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.11M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap AreaOfLand Area of Land sqft 4,087 2014-10-31 2016 Q1 10-Q 2016-05-13 0001640334-16-001069
us-gaap AssetAcquisitionConsiderationTransferredTransactionCost AssetAcquisitionConsiderationTransferredTransactionCost USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap Assets Assets USD 5.07M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap AssetsCurrent Assets, Current USD 5.04M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap AssetsHeldForSaleNotPartOfDisposalGroupCurrent Assets Held-for-sale, Not Part of Disposal Group, Current USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap BridgeLoan Bridge Loan USD 900,000 2018-12-31 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap CargoAndFreightRevenue Cargo and Freight Revenue (Deprecated 2018-01-31) USD 207,271 2013-11-01 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap Cash Cash USD 83.34M 2024-03-31 2024 Q1 10-Q 2024-05-10 0001516551-24-000055
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 4.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 21.32M 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 639,461 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 4.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 4.82M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 2.39M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-06 0001640334-20-002732
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 25,842 2022-12-31 2022 FY 10-K 2023-03-31 0001516551-23-000038
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 25 2023-09-30 2023 Q3 10-Q 2023-11-14 0001516551-23-000100
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 22,425 2016-12-31 2016 FY 10-K 2017-03-10 0001640334-17-000456
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 5.00M 2026-08-21 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 867,306 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 15.20M 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 37.50M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 4.42M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 4.42M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,423 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap CommonStockValueOutstanding Common Stock, Value, Outstanding USD 3,147 2013-07-31 2013 Q3 10-Q 2013-09-16 0001557240-13-000264
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -6.01M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001516551-21-000020
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 1.95M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-23 0001640334-20-000582
us-gaap ConversionOfStockSharesIssued1 Conversion of Stock, Shares Issued shares 900,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001640334-18-000968
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 2.76M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001516551-24-000070
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-03-28 0001516551-22-000004
us-gaap CostOfServicesAmortization Cost of Services, Amortization (Deprecated 2018-01-31) USD 29,800 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001557240-15-000300
us-gaap CumulativeTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Cumulative Translation Adjustment, Net of Tax, Period Increase (Decrease) USD 96,190 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 5,400 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 5,400 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent Debt Instrument, Convertible, Carrying Amount of Equity Component USD 790,691 2020-06-30 2020 Q2 10-Q 2020-08-13 0001640334-20-002095
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0001516551-23-000038
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD 137,192 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-14 0001640334-19-002291
us-gaap DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent USD 73,368 2022-12-31 2022 FY 10-K 2023-03-31 0001516551-23-000038
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 1.39M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 6.43M 2024-03-31 2025 Q3 10-Q 2025-11-10 0001628280-25-051031
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0001516551-23-000038
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -2,819 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap DeferredIncomeTaxesAndOtherTaxReceivableCurrent Deferred Income Taxes and Other Tax Receivable, Current USD 4,464 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 55,996 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 2,450 2016-12-31 2017 FY 10-K 2018-03-19 0001640334-18-000482
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 3,233 2015-12-31 2016 FY 10-K 2017-03-10 0001640334-17-000456
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -6.56M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 9.35M 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 74.39M 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 55,996 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 50.22M 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 30.31M 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 13.21M 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 331,584 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxAssetsStateTaxes Deferred Tax Assets, State Taxes USD 714 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 76,632 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 40,528 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.90M 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements USD 434,504 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 0 2017-12-31 2017 FY 10-K 2018-03-19 0001640334-18-000482
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 74.33M 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 226,897 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0001516551-23-000038
us-gaap DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals USD -638,754 2015-12-31 2016 FY 10-K 2017-03-10 0001640334-17-000456
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 55,996 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 663,197 2023-12-31 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap Depreciation Depreciation USD 540,135 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 361,809 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap DerivativeLiabilities Derivative Liability USD 326 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 3 2022-12-31 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2020-12-31 2021 FY 10-K 2022-03-28 0001516551-22-000004
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 3.83M 2015-03-31 2015 Q1 10-Q 2015-05-13 0001557240-15-000300
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD -345,473 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0001516551-22-000004
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD -10,794 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap DueFromAffiliateCurrent Due from Affiliate, Current USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap DueFromOtherRelatedPartiesCurrent Due from Other Related Parties, Current USD 22,542 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-31 0001516551-23-000038
us-gaap DueFromRelatedPartiesNoncurrent Due from Related Parties, Noncurrent USD 4,000 2021-06-30 2021 Q2 10-Q 2021-08-06 0001628280-21-015972
us-gaap DueToOtherRelatedPartiesClassifiedCurrent Due to Other Related Parties, Current USD 0 2023-09-30 2023 Q3 10-Q 2023-11-14 0001516551-23-000100
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -4.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.11 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-10 0001640334-19-000805
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -4.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.205 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.012 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 274,019 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 134,686 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 11.76M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 5.07M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ExtinguishmentOfDebtGainLossIncomeTax Extinguishment of Debt, Gain (Loss), Income Tax USD 33,925 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-12 0001640334-17-000931
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.7 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-12 0001640334-17-000931
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.016 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-12 0001640334-17-000931
us-gaap ForeignCurrencyExchangeRateTranslation1 Foreign Currency Exchange Rate, Translation pure 0.73 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap ForeignCurrencyTransactionGainLossRealizedAfterTax ForeignCurrencyTransactionGainLossRealizedAfterTax USD -1.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 1.22M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 178,200 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD -597,275 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001628280-26-056968
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -603,540 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 4.23M 2024-01-01 2024-12-31 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -307,086 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 12.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 589,660 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -56.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -23.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 323,157 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -6.56M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap IncomeTaxesPaid Income Taxes Paid USD 3,400 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 5,141 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 3,678 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 3,400 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD 1.83M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 11.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 6,070 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Amount USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -67,862 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -11.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 916,325 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 175,360 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -46,422 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 114,486 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 132,366 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001516551-23-000038
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 4,265 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 695,831 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 1.37M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 234,531 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 167,355 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001557240-14-000691
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 415,013 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 1,190 2013-11-01 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD 588 2011-03-16 2013-07-31 2013 Q3 10-Q 2013-09-16 0001557240-13-000264
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 36,684 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-10 0001640334-19-000805
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -42,333 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001640334-18-002123
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap IncreaseDecreaseInDueToOtherRelatedPartiesCurrent Increase (Decrease) in Due to Other Related Parties, Current USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -1.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncreaseDecreaseInNotesPayableRelatedPartiesCurrent Increase (Decrease) in Notes Payable, Related Parties, Current USD 11,400 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-06 0001640334-20-002732
us-gaap IncreaseDecreaseInOperatingAssets Increase (Decrease) in Operating Assets USD -4,470 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-13 0001557240-15-000300
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -264,194 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0001516551-25-000042
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -839,599 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncreaseDecreaseInOtherCurrentLiabilities Increase (Decrease) in Other Current Liabilities USD -1.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -45,601 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -121,277 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -619,769 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -33,072 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-19 0001640334-18-000482
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD -33,072 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001640334-17-002417
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 37,500 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-10 0001640334-17-000456
us-gaap InducedConversionOfConvertibleDebtExpense Induced Conversion of Convertible Debt Expense USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap InsuranceRecoveries Insurance Recoveries USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap InterestExpense Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap InterestExpenseDebt Interest Expense, Debt USD 3,102 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-07 0001516551-23-000044
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 8,797 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap InterestExpenseOther Interest Expense, Other USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 76,227 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001516551-23-000100
us-gaap InterestIncomeOther Interest Income, Other USD 74 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-14 0001640334-19-002291
us-gaap InterestIncomeRelatedParty Interest Income, Related Party USD 304 2012-11-01 2013-10-31 2013 FY 10-K 2014-01-27 0001557240-14-000036
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-10 0001640334-18-001536
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 8,797 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 321,922 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap InvestmentTaxCredit Investment Tax Credit USD 170,773 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001516551-23-000100
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 22,245 2017-01-01 2017-06-30 2018 Q2 10-Q 2018-08-10 0001640334-18-001536
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 19,654 2017-11-03 2017-11-30 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 288,812 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 215,127 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 85,936 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 202,876 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 25,427 2023-09-30 2023 Q3 10-Q 2023-11-14 0001516551-23-000100
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 15,166 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap Liabilities Liabilities USD 3.71M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 5.07M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap LiabilitiesCurrent Liabilities, Current USD 3.71M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 551,322 2017-12-31 2018 Q2 10-Q 2018-08-10 0001640334-18-001536
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap LineOfCreditFacilityFairValueOfAmountOutstanding Line of Credit Facility, Fair Value of Amount Outstanding USD 2.56M 2022-03-31 2022 Q1 10-Q 2022-05-06 0001516551-22-000006
us-gaap LoansPayableCurrent Loans Payable, Current USD 35,763 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap LongTermDebt Long-term Debt USD 45,598 2020-09-30 2020 Q3 10-Q 2020-11-06 0001640334-20-002732
us-gaap LongTermLineOfCredit Long-term Line of Credit, Noncurrent USD 450,000 2021-09-30 2021 Q3 10-Q 2021-11-10 0001516551-21-000020
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 43,006 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 222,839 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap LossContingencyAccrualCarryingValueCurrent Loss Contingency, Accrual, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap LossContingencyAccrualProvision Loss Contingency Accrual, Provision USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap LossContingencyEstimateOfPossibleLoss Loss Contingency, Estimate of Possible Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap MaintenanceCosts Maintenance Costs (Deprecated 2018-01-31) USD 45,155 2013-11-01 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -289,251 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 3.74M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001640334-18-000968
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 20.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -1,059 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001640334-18-000968
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -20.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -1.05M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-15 0001640334-18-000968
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -23.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -23.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -23.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 485,923 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 12,827 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap NotesAndLoansReceivableNetNoncurrent Financing Receivable, after Allowance for Credit Loss, Noncurrent USD 3,600 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap NotesPayable Notes Payable USD 49,664 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap NotesPayableCurrent Notes Payable, Current USD 6,658 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 30,772 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 30,772 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 15,851 2013-04-30 2013 Q2 10-Q 2013-06-27 0001557240-13-000182
us-gaap NotesReceivableNet Financing Receivable, after Allowance for Credit Loss USD 16,427 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap NotesReceivableRelatedParties Notes Receivable, Related Parties USD 9,574 2012-10-31 2013 FY 10-K 2014-01-27 0001557240-14-000036
us-gaap NotesReceivableRelatedPartiesCurrent Notes Receivable, Related Parties, Current USD 5,038 2012-10-31 2013 FY 10-K 2014-01-27 0001557240-14-000036
us-gaap NotesReceivableRelatedPartiesNoncurrent Notes Receivable, Related Parties, Noncurrent USD 4,536 2012-10-31 2013 FY 10-K 2014-01-27 0001557240-14-000036
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OperatingExpenses Operating Expenses USD 23.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -23.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OperatingLeaseCost Operating Lease, Cost USD 207,400 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 273,646 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 9,452 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 8,580 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 170,367 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 8,066 2017-09-30 2017 Q3 10-Q 2017-11-14 0001640334-17-002417
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 8,066 2017-09-30 2017 Q3 10-Q 2017-11-14 0001640334-17-002417
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 0 2017-09-30 2017 Q3 10-Q 2017-11-14 0001640334-17-002417
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 0 2017-09-30 2017 Q3 10-Q 2017-11-14 0001640334-17-002417
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 0 2017-09-30 2017 Q3 10-Q 2017-11-14 0001640334-17-002417
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 0 2017-09-30 2017 Q3 10-Q 2017-11-14 0001640334-17-002417
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2017-09-30 2017 Q3 10-Q 2017-11-14 0001640334-17-002417
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 43,102 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.108 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 30.48M 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 3,767 2018-09-30 2018 Q3 10-Q 2018-11-14 0001640334-18-002123
us-gaap OtherAssetsCurrent Other Assets, Current USD 12,437 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OtherAssetsMiscellaneousCurrent Other Assets, Miscellaneous, Current USD 7,973 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 8,309 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.08M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OtherLoansPayableCurrent Other Loans Payable, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-28 0001516551-22-000004
us-gaap OtherLoansPayableLongTerm Other Loans Payable, Long-term, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-03-28 0001516551-22-000004
us-gaap OtherLongTermDebtCurrent Other Long-term Debt, Current USD 0 2023-12-31 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 0 2021-12-31 2021 FY 10-K 2022-03-28 0001516551-22-000004
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -5,402 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 86,385 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap OtherSundryLiabilitiesCurrent Other Sundry Liabilities, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap PaymentsForProceedsFromPreviousAcquisition Payments for (Proceeds from) Previous Acquisition USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap PaymentsForProceedsFromShortTermInvestments Payments for (Proceeds from) Short-term Investments USD -19.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001628280-25-051031
us-gaap PaymentsOfDerivativeIssuanceCosts Payments of Derivative Issuance Costs USD -137,192 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-23 0001640334-20-000582
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 6.43M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap PaymentsToAcquireFurnitureAndFixtures Payments to Acquire Furniture and Fixtures USD 1,650 2017-11-03 2017-11-30 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 17,433 2011-03-16 2013-07-31 2013 Q3 10-Q 2013-09-16 0001557240-13-000264
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 436,554 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 19.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 4.50M 2016-03-31 2016 Q1 10-Q 2016-05-13 0001640334-16-001069
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 200,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 321,497 2021-09-30 2021 Q3 10-Q 2021-11-10 0001516551-21-000020
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 206,984 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 21,238 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap PrepaidInsurance Prepaid Insurance USD 120,599 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 450,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap ProceedsFromDivestitureOfBusinessesNetOfCashDivested Proceeds from Divestiture of Businesses, Net of Cash Divested USD 178,200 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 9,301 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-10 0001640334-19-000805
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 32,000 2012-11-01 2013-10-31 2013 FY 10-K 2014-01-27 0001557240-14-000036
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 1.13M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-14 0001640334-18-002123
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 83.56M 2024-01-01 2024-03-31 2025 Q3 10-Q 2025-11-10 0001628280-25-051031
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001516551-23-000038
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 7.17M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001640334-18-002123
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0001516551-22-000004
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 116,700 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-06 0001640334-20-002732
us-gaap ProceedsFromOtherShortTermDebt Proceeds from Other Short-term Debt USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0001516551-22-000004
us-gaap ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans Proceeds from Repayment of Loans by Employee Stock Ownership Plans USD 6,274 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ProceedsFromSaleAndCollectionOfNotesReceivable Proceeds from Sale and Collection of Notes Receivable USD 21,231 2013-11-01 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap ProceedsFromSaleOfNotesReceivable Proceeds from Sale of Notes Receivable USD 9,574 2012-11-01 2013-07-31 2013 Q3 10-Q 2013-09-16 0001557240-13-000264
us-gaap ProceedsFromSaleOfOtherAssetsInvestingActivities Proceeds from Sale of Other Assets, Investing Activities USD 850 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 1.22M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 11,000 2012-11-01 2013-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 29,571 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 85.65M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-10 0001516551-24-000055
us-gaap ProfessionalFees Professional Fees USD 22,993 2013-11-01 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 105,384 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 20,430 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 1.04M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 9,301 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-14 0001640334-19-002291
us-gaap RepaymentsOfDebt Repayments of Debt USD 16,802 2013-11-01 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 6,190 2013-11-01 2014-01-31 2014 Q1 10-Q 2014-03-17 0001557240-14-000144
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 286,100 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001516551-24-000110
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 2.97M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-07 0001516551-23-000044
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 13.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 21.22M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001516551-23-000100
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 0 2025-09-30 2025 Q3 10-Q 2025-11-10 0001628280-25-051031
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -210.10M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 61,342 2013-11-01 2014-07-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 743,716 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number shares 147,250 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.17 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-12 0001640334-17-000931
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 37.50M 2026-05-26 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 14.78M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.08 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 13,281 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001516551-21-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 178,914 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.68M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 4.35M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.14 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0001516551-21-000020
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 325,929 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 0.25 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 37.76M 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.07 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 0.25 2020-12-31 2020 FY 10-K 2021-03-02 0001640334-21-000483
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2022-03-31 2022 Q1 10-Q 2022-05-06 0001516551-22-000006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 34.37M 2022-03-31 2022 Q1 10-Q 2022-05-06 0001516551-22-000006
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 0.07 2022-03-31 2022 Q1 10-Q 2022-05-06 0001516551-22-000006
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 126,959 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001628280-26-033417
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 339,063 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0.06 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0.08 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.04 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 0.04 2022-12-31 2022 FY 10-K 2023-03-31 0001516551-23-000038
us-gaap SharesIssued Shares, Issued shares 33.62M 2017-12-31 2017 FY 10-K 2018-03-19 0001640334-18-000482
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.16 2021-06-30 2021 Q2 10-Q 2021-08-06 0001628280-21-015972
us-gaap SharesOutstanding Shares, Outstanding shares 3.62M 2014-01-31 2014 Q1 10-Q 2014-03-17 0001557240-14-000144
us-gaap ShortTermBorrowings Short-term Debt USD 71,102 2020-09-30 2020 Q3 10-Q 2020-11-06 0001640334-20-002732
us-gaap ShortTermInvestments Short-term Investments USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 145,200 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 1.91M 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001628280-25-051031
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.36M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.125 2026-08-24 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap StockIssued1 Stock Issued USD 168,000 2015-01-01 2015-09-30 2016 Q3 10-Q 2016-11-09 0001640334-16-001933
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 33,131 2022-11-10 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 968,973 2024-08-08 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 1,050 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap StockIssuedDuringPeriodSharesIssuedForCash Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) shares 3.62M 2011-03-16 2014-10-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 24,000 2015-03-01 2015-03-31 2016 FY 10-K 2017-03-10 0001640334-17-000456
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap StockIssuedDuringPeriodSharesStockSplits Stock Issued During Period, Shares, Stock Splits shares 26,349 2023-09-06 2023 FY 10-K 2024-03-22 0001516551-24-000048
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 5,618 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 4.97M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan Stock Issued During Period, Value, Employee Stock Ownership Plan USD 29,571 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 6,274 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 86,700 2011-03-16 2014-10-31 2014 Q3 10-Q 2014-09-15 0001557240-14-000510
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 187,550 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 83.56M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 50,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-19 0001640334-18-000482
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 62,500 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-10 0001640334-17-000456
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.80M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap StockIssuedDuringPeriodValueStockDividend Stock Issued During Period, Value, Stock Dividend USD 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 4.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001516551-23-000038
us-gaap StockOptionExercisePriceDecrease Stock Option, Exercise Price, Decrease USD/shares 4.917 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 1.36M 2016-09-30 2016 Q3 10-Q 2016-11-09 0001640334-16-001933
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 4.50M 2016-09-30 2016 Q3 10-Q 2016-11-09 0001640334-16-001933
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2018-12-31 2018 FY 10-K 2019-03-14 0001640334-19-000379
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 20.00M 2019-03-31 2019 Q1 10-Q 2019-05-10 0001640334-19-000805
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 4,492 2016-09-30 2016 Q3 10-Q 2016-11-09 0001640334-16-001933
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 4,492 2016-09-30 2016 Q3 10-Q 2016-11-09 0001640334-16-001933
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 59,406 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0001516551-22-000040
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 14.53M 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 397 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 5.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0001516551-25-000027
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 0 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 6.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-10 0001628280-26-016394
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 2.01M 2019-03-31 2019 Q1 10-Q 2019-05-10 0001640334-19-000805
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 4.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 132.73M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-10 0001640334-19-000805
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 4.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001628280-26-073810

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →